Status:
COMPLETED
Warfarin and Coronary Calcification Project
Lead Sponsor:
Walter Reed Army Medical Center
Conditions:
Coronary Calcification
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to assess whether the use of warfarin, a commonly used anticoagulation drug, is associated with increased amounts of coronary artery calcification. Studies in animals and p...
Eligibility Criteria
Inclusion
- Age 18 years of age or older
- Patients referred to begin or already treated with warfarin anticoagulation therapy.
Exclusion
- Known prior myocardial infarction or coronary heart disease
- History of advanced chronic kidney disease manifested by serum creatinine\>2 or calculated glomerular filtration rate (GFR)\<30
- History of hyperparathyroidism
- Current hypercalcemia
- Current hyperphosphatemia
- Uncertain duration of warfarin therapy
- Lack of records documenting international normalized ratio (INR) during therapy
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00868712
Start Date
May 1 2004
End Date
January 1 2010
Last Update
August 24 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States, 20307